Natriuretic Peptide, Brain
"Natriuretic Peptide, Brain" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A PEPTIDE that is secreted by the BRAIN and the HEART ATRIA, stored mainly in cardiac ventricular MYOCARDIUM. It can cause NATRIURESIS; DIURESIS; VASODILATION; and inhibits secretion of RENIN and ALDOSTERONE. It improves heart function. It contains 32 AMINO ACIDS.
Descriptor ID |
D020097
|
MeSH Number(s) |
D06.472.699.584.625 D12.644.548.585.625 D12.776.641.590
|
Concept/Terms |
Natriuretic Peptide, Brain- Natriuretic Peptide, Brain
- Peptide, Brain Natriuretic
- Brain Natriuretic Peptide
- BNP-32
- BNP 32
- Nesiritide
- B-Type Natriuretic Peptide
- Natriuretic Peptide, B-Type
- BNP Gene Product
- Type-B Natriuretic Peptide
- Natriuretic Peptide, Type-B
- Type B Natriuretic Peptide
- Natriuretic Peptide Type-B
- Natriuretic Peptide Type B
- Natriuretic Factor-32
- Natriuretic Factor 32
- Brain Natriuretic Peptide-32
- Brain Natriuretic Peptide 32
- Natriuretic Peptide-32, Brain
- Peptide-32, Brain Natriuretic
|
Below are MeSH descriptors whose meaning is more general than "Natriuretic Peptide, Brain".
Below are MeSH descriptors whose meaning is more specific than "Natriuretic Peptide, Brain".
This graph shows the total number of publications written about "Natriuretic Peptide, Brain" by people in this website by year, and whether "Natriuretic Peptide, Brain" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 0 | 1 | 2003 | 2 | 1 | 3 | 2004 | 2 | 0 | 2 | 2005 | 1 | 1 | 2 | 2006 | 2 | 1 | 3 | 2013 | 3 | 1 | 4 | 2014 | 1 | 0 | 1 | 2015 | 1 | 0 | 1 | 2016 | 0 | 1 | 1 | 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Natriuretic Peptide, Brain" by people in Profiles.
-
Roubicek T, Stros J, Kucera P, Nedbal P, Cerny J, Polasek R, Wichterle D. Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome. PLoS One. 2019; 14(7):e0219966.
-
Yeboah J, Bertoni A, Qureshi W, Aggarwal S, Lima JA, Kawel-Boehm N, Bluemke DA, Shah SJ. Pedal Edema as an Indicator of Early Heart Failure in the Community: Prevalence and Associations With Cardiac Structure/Function and Natriuretic Peptides (MESA [Multiethnic Study of Atherosclerosis]). Circ Heart Fail. 2016 12; 9(12).
-
AbouEzzeddine OF, Wong YW, Mentz RJ, Raza SS, Nativi-Nicolau J, Kociol RD, McNulty SE, Anstrom KJ, Hernandez AF, Redfield MM. Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score. J Card Fail. 2016 Nov; 22(11):853-858.
-
Shaikh AY, Esa N, Martin-Doyle W, Kinno M, Nieto I, Floyd KC, Browning C, Ennis C, Donahue JK, Rosenthal LS, McManus DD. Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation. Crit Pathw Cardiol. 2015 Dec; 14(4):157-65.
-
Bajaj A, Rathor P, Sehgal V, Kabak B, Shetty A, Al Masalmeh O, Hosur S. Prognostic Value of Biomarkers in Acute Non-massive Pulmonary Embolism: A Systematic Review and Meta-analysis. Lung. 2015 Oct; 193(5):639-51.
-
Sinner MF, Stepas KA, Moser CB, Krijthe BP, Aspelund T, Sotoodehnia N, Fontes JD, Janssens AC, Kronmal RA, Magnani JW, Witteman JC, Chamberlain AM, Lubitz SA, Schnabel RB, Vasan RS, Wang TJ, Agarwal SK, McManus DD, Franco OH, Yin X, Larson MG, Burke GL, Launer LJ, Hofman A, Levy D, Gottdiener JS, Kääb S, Couper D, Harris TB, Astor BC, Ballantyne CM, Hoogeveen RC, Arai AE, Soliman EZ, Ellinor PT, Stricker BH, Gudnason V, Heckbert SR, Pencina MJ, Benjamin EJ, Alonso A. B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies. Europace. 2014 Oct; 16(10):1426-33.
-
Roy AK, McCullagh BN, Segurado R, McGorrian C, Keane E, Keaney J, Fitzgibbon MN, Mahon NG, Murray PT, Gaine SP. Detection of high-sensitivity troponin in outpatients with stable pulmonary hypertension identifies a subgroup at higher risk of adverse outcomes. J Card Fail. 2014 Jan; 20(1):31-7.
-
Rienstra M, Yin X, Larson MG, Fontes JD, Magnani JW, McManus DD, McCabe EL, Coglianese EE, Amponsah M, Ho JE, Januzzi JL, Wollert KC, Fradley MG, Vasan RS, Ellinor PT, Wang TJ, Benjamin EJ. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation. Am Heart J. 2014 Jan; 167(1):109-115.e2.
-
Uraizee I, Cheng S, Hung CL, Verma A, Thomas JD, Zile MR, Aurigemma GP, Solomon SD. Relation of N-terminal pro-B-type natriuretic peptide with diastolic function in hypertensive heart disease. Am J Hypertens. 2013 Oct; 26(10):1234-41.
-
Tanaka K, Essick EE, Doros G, Tanriverdi K, Connors LH, Seldin DC, Sam F. Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis. J Am Heart Assoc. 2013 Mar 12; 2(2):e005868.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|